{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,21]],"date-time":"2026-11-21T01:56:14Z","timestamp":1795226174288,"version":"4.10.3"},"reference-count":28,"publisher":"Wiley","issue":"12","license":[{"start":{"date-parts":[[2008,3,10]],"date-time":"2008-03-10T00:00:00Z","timestamp":1205107200000},"content-version":"vor","delay-in-days":2656,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Aust Veterinary J"],"published-print":{"date-parts":[[2000,12]]},"abstract":"<jats:p><jats:bold>Objective<\/jats:bold>The syndrome of inappropriate secretion of antidiuretic hormone is a rare disorder in dogs characterised by hypo\u2010osmolality and persistent arginine vasopressin production in the absence of hypovolaemia and\/or hypotension. The study describes the efficacy and safety of the nonpeptide selective arginine vasopressin V<jats:sub>2<\/jats:sub>receptor antagonist OPC\u201031260 in a dog with the naturally occurring syndrome.<\/jats:p><jats:p><jats:bold>Design<\/jats:bold>The detailed case history of a dog with spontaneous syndrome of inappropriate secretion of antidiuretic hormone that received long\u2010term therapy with oral OPC\u201031260 is presented. Effects of the first dose of OPC\u201031260 and of a dose administered after a continuous dosing period of 12 days are reported.<\/jats:p><jats:p><jats:bold>Procedure<\/jats:bold>Packed cell volume, plasma sodium, total protein, arginine vasopressin, renin activity, atrial natriuretic peptide, urine specific gravity, urine output, heart rate and body weight were monitored for 2 h before, and for 4 h after, the first dose of OPC\u201031260. The same parameters plus plasma osmolality and urine osmolality were monitored when an identical dose was administered after 12 days of therapy.<\/jats:p><jats:p><jats:bold>Results<\/jats:bold>Oral administration of OPC\u201031260 at 3 mg\/kg body weight resulted in marked aquaresis with increased urine output and decline in urine specific gravity within 1 h. Corresponding increases in concentrations of plasma sodium, plasma osmolality and plasma renin activity were recorded over a 4 h period. Arginine vasopressin concentration remained inappropriately elevated throughout the study.<\/jats:p><jats:p><jats:bold>Results<\/jats:bold>were similar when the trial procedure was repeated after a stabilisation period of 12 days. Long\u2010term therapy with OPC\u201031260 at a dose of 3 mg\/kg body weight orally every 12 h resulted in good control of clinical signs with no deleterious effects detected during a 3\u2010year follow\u2010up period. Despite sustained clinical benefits observed in this case, plasma sodium did not normalise with continued administration of the drug.<\/jats:p><jats:p><jats:bold>Conclusions<\/jats:bold>Treatment of a dog with naturally occurring syndrome of inappropriate secretion of antidiuretic hormone with OPC\u201031260 at 3 mg\/kg body weight orally every 12 h resulted in marked aquaresis and significant palliation of clinical signs with no discernible side\u2010effects detected over a 3\u2010year period. Thus, OPC\u201031260 appears to offer a feasible medical alternative to water restriction for treatment of dogs with syndrome of inappropriate secretion of antidiuretic hormone. Higher doses of OPC\u201031260 may be required to achieve and maintain normal plasma sodium in dogs with this syndrome.<\/jats:p>","DOI":"10.1111\/j.1751-0813.2000.tb10497.x","type":"journal-article","created":{"date-parts":[[2008,3,10]],"date-time":"2008-03-10T17:37:40Z","timestamp":1205170660000},"page":"825-830","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Effects of an oral vasopressin receptor antagonist (OPC\u201031260) in a dog with syndrome of inappropriate secretion of antidiuretic hormone"],"prefix":"10.1111","volume":"78","author":[{"given":"LM","family":"FLEEMAN","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"PJ","family":"IRWIN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"PA","family":"PHILLIPS","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"WEST","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2008,3,10]]},"reference":[{"key":"e_1_2_2_2_2","doi-asserted-by":"publisher","DOI":"10.1530\/acta.0.1170059"},{"key":"e_1_2_2_3_2","first-page":"2003","volume-title":"Harrisons Principles of Internal Medicine","author":"Moses AM","year":"1998"},{"key":"e_1_2_2_4_2","first-page":"97","article-title":"Syndrome of inappropriate secretion of antidiuretic hormone (SIADH) in malignant disease","volume":"238","author":"Sorenson JB","year":"1995","journal-title":"J Vet Intern Med"},{"key":"e_1_2_2_5_2","first-page":"181","article-title":"Inappropriate secretion of antidiuretic hormone in a dog","volume":"175","author":"Breitschwerdt EB","year":"1979","journal-title":"J Am Vet Med Assoc"},{"issue":"1","key":"e_1_2_2_6_2","first-page":"104","article-title":"Inappropriate vasopressin secretion in dogs","volume":"113","author":"Biewenga WJ","year":"1988","journal-title":"Tijdschr Diergeneeskd"},{"key":"e_1_2_2_7_2","first-page":"423","article-title":"Syndrome of inappropriate antidiuretic hormone secretion in a dog","volume":"30","author":"Houston DM","year":"1989","journal-title":"Can Vet J"},{"key":"e_1_2_2_8_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-1003303"},{"issue":"6","key":"e_1_2_2_9_2","first-page":"H2245","article-title":"Effects of oral AVP receptor antagonists OPC\u201021268 and OPC\u201031260 on congestive heart failure in conscious dogs","volume":"267","author":"Naitoh M.","year":"1994","journal-title":"Am J Physiol"},{"key":"e_1_2_2_10_2","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1016\/S0022-3565(24)36542-5","article-title":"Comparison of the water diuretic activity of kappa receptor agonists and a vasopressin receptor antagonist in dogs","volume":"280","author":"Brooks DP","year":"1997","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_2_2_11_2","doi-asserted-by":"publisher","DOI":"10.1159\/000414827"},{"key":"e_1_2_2_12_2","first-page":"401","article-title":"Current concept of the role of antidiuretic hormone in osmoregulation and volume regulation in man","volume":"28","author":"Meinders AE","year":"1985","journal-title":"Neth J Med"},{"key":"e_1_2_2_13_2","doi-asserted-by":"crossref","unstructured":"PullanPT JohnstonCI AndersonWP KornerPI.The role of vasopressin in blood pressure control and in experimental hypertension.Clin Sci Mol Med1978;4 Suppl:251S\u2013254S.","DOI":"10.1042\/cs055251s"},{"key":"e_1_2_2_14_2","doi-asserted-by":"publisher","DOI":"10.5694\/j.1326-5377.1971.tb87472.x"},{"key":"e_1_2_2_15_2","doi-asserted-by":"publisher","DOI":"10.1080\/01971529008053267"},{"key":"e_1_2_2_16_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.RES.59.3.256"},{"key":"e_1_2_2_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(67)90096-4"},{"key":"e_1_2_2_18_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02254219"},{"issue":"25","key":"e_1_2_2_19_2","first-page":"52","article-title":"Vasopressin and blood pressure","volume":"34","author":"Thibonnier M.","year":"1988","journal-title":"Kidney Int"},{"key":"e_1_2_2_20_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.1992.tb09058.x"},{"key":"e_1_2_2_21_2","first-page":"794","volume-title":"Proceedings of the 25th Annual Meeting of the American Society of Nephrology","author":"Ishikawa S.","year":"1992"},{"key":"e_1_2_2_22_2","first-page":"R934","article-title":"Arginine vasopressin produces renal vasodilation via V2 receptors in conscious dogs","volume":"265","author":"Naitoh M.","year":"1993","journal-title":"Am J Physiol"},{"key":"e_1_2_2_23_2","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1993.207"},{"key":"e_1_2_2_24_2","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.82.4.3900"},{"key":"e_1_2_2_25_2","doi-asserted-by":"publisher","DOI":"10.1159\/000190149"},{"key":"e_1_2_2_26_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1939-1676.1994.tb03194.x"},{"key":"e_1_2_2_27_2","first-page":"2035","volume-title":"Harrisons Principles of Internal Medicine.","author":"Williams GH","year":"1998"},{"key":"e_1_2_2_28_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1439-0442.1994.tb00122.x"},{"key":"e_1_2_2_29_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.me.31.020180.001531"}],"container-title":["Australian Veterinary Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1751-0813.2000.tb10497.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1751-0813.2000.tb10497.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,29]],"date-time":"2025-01-29T01:04:46Z","timestamp":1738112686000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1751-0813.2000.tb10497.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,12]]},"references-count":28,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2000,12]]}},"alternative-id":["10.1111\/j.1751-0813.2000.tb10497.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1751-0813.2000.tb10497.x","archive":["Portico"],"relation":{},"ISSN":["0005-0423","1751-0813"],"issn-type":[{"value":"0005-0423","type":"print"},{"value":"1751-0813","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,12]]},"assertion":[{"value":"2008-03-10","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}